What great news!
Despite the nasty side effects, you must be pleased.
I’m sure all of us on GRG are elated.
On Wed, Aug 20, 2014 at 10:22 AM, L. Stephen Coles M.D. Ph.D. wrote:
To Members and Friends of the Los Angeles Gerontology Research
additional good news about my health status from yesterday’s
CA-19-9 is blood biomarker of pancreatic cancer cells metastasizing
to other organs,
like the liver in my own case. The normal range for patients
without cancer is <= 34 U/ml.
It is not a reliable marker in general, but I believe trends are.
Here are my recent lab values…Date CA-19-9 level (U/ml)3/03/14 1471
As you can see at a glance, it is monotonically
decreasing into the normal range since the start
of my first cycle of Taxotere chemotherapy. Abdominal CT-Scan
reports from the radiologists are
consistent with a reduction in my right-lobe liver tumor volume.
Can someone help me by plotting this data as a graph
using Excel, since I am now exhausted from
the side effects of the new three-week cycle of chemo that I started
The job of an oncologist is to kill the cancer without
killing the patient due to side effects. I have
now had to resort to one finger typing due to the side effects of
bilateral sensory neuropathy in my hands,
although you couldn't tell what my slow typing speed was when you read
this message unless I told you.
Curiously, my sensory artifact doesn't include temperature (I can tell
hot and cold), but I can no longer feel
the wetness of water or perform routine tasks like buttoning buttons,
zippering zippers, or tying my own
shoe laces. My handwriting is now essentially illegible, so we're
lucky to have keyboard/mouse technology.
But soon I may have to buy a copy of Dragon Dictate for an exclusive
voice interface if things get any worse.
— Steve Coles
L. Stephen Coles, M.D., Ph.D., Cofounder
Los Angeles Gerontology Research GroupE-mail: email@example.comE-mail: